/Investor DB

Keyhorse Capital — 2025 Investments

6 investments dated 2025 · listed companies and verified rows first · show all

Aquisenseaquisense.comin𝕏Mar 2025

AquiSense develops UV-C LED water disinfection systems that treat water without chemicals, serving homes, factories, restaurants, remote communities, and space applications.

CleantechDeep TechHardwareKentucky, US

Oliver Lawal(President & CEO)inStuart Bauman(CFO/Treasurer)inJennifer Pagán(CTO)in

PartnerKelby Price· solo GP

Co-investorsBURNT ISLAND VENTURES

Feedcoyotefeedcoyote.comin𝕏Dec 2025

Feed Coyote is an all-in-one project management platform designed for freelancers and professionals to collaborate, communicate, and manage work across 130+ countries.

AI & Machine LearningB2B MarketplacesFintechFuture of WorkSaaSPaducah, US

Stevens Bonhomme(Executive Officer, Director)in

PartnerKelby Price· solo GP

Co-investorsBlue StartupsNex CubedTechstars

Krew Technologiesgetkrew.aiJul 2025

Krew makes Krewmate, a system that captures and organizes production radio (walkie) traffic into a live, time-stamped record of a film shoot day, tracking holds, delays, arrivals and incidents.

AI & Machine LearningMedia & EntertainmentSaaSNicholasville, US

JOSIAH ANDREW LANGENBRUCH STENDEL(Chief Executive Officer)LUKE ANDREW THOMPSON(Chief Operating Officer)JACOB BRIAN WINDLE(Chief Technology Officer)

PCC Hydrogenpcchydrogen.cominDec 2025

PCC Hydrogen produces green hydrogen by converting ethanol, other biofuels, and renewable natural gas into high-purity hydrogen using a patented Pyrocat crystalline catalyst and a production process that yields a capturable pure CO2 byproduct.

CleantechClimate TechEnergyLouisville, US

Jeffrey Harrison(President and Chief Technology Officer)inTimothy Fogarty(Chief Executive Officer)

BoardMatt Hurlock(Director)Ben Streepey(Director)inSteve Gallo(Director)Timothy Applberry(Director)

Co-investorsBluegrass Angel Venture

Simbryotechsimbryotech.cominSep 2025

Simbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility.

AI & Machine LearningBiotechDigital HealthFemTechMedical DevicesHouston, US

Yael Katz(Executive Officer, Director)inAryeh Warmflash(Executive Officer)Stephen Rooks(Director)Andrea Mazzocchi(Director)in

Co-investorsTSVC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

TalnFlo

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.